Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02293369
Other study ID # 1424
Secondary ID
Status Completed
Phase N/A
First received November 13, 2014
Last updated January 7, 2016
Start date November 2014
Est. completion date November 2015

Study information

Verified date January 2016
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

American Congress of Obstetricians and Gynecologists (ACOG) advises minimally invasive methods in gynecological surgery to ensure increased benefits to the patient and reduce potential hospitalization costs.

Laparoscopic hysterectomy has become the standard approach in gynecological benign disorders. During laparoscopic hysterectomy, vaginal cuff can be closed with different sutures, techniques and approaches, which is one of the challenges of this surgery. Data is limited on potential impact of different sutures, techniques and approaches for vaginal cuff closure on female sexual function in relation to vaginal length.

Various studies in the literature evaluated different approaches (abdominal, vaginal, laparoscopic, robotic-assisted laparoscopic). In addition, for cuff closure, different techniques (interrupted, continuous) and sutures (barbed, Vicryl) were compared. Measures like operation time, cuff healing, complications, cost effectiveness, etc. were usually measured. However, there is no prospective randomized clinical study in the literature that compares laparoscopic approach with vaginal route for cuff closure in terms of female sexual function in relation to vaginal length.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date November 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients scheduled to have total laparoscopic hysterectomy because of benign conditions only

Exclusion Criteria:

- Suspicion of malignancy

- Presence of large adnexal masses (maximum diameter >10 cm at preoperative ultrasonography)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Cuff closure via vaginal route
Vaginal cuff will be closed via vaginal route during total laparoscopic hysterectomy.
Cuff closure via laparoscopic route
Vaginal cuff will be closed via laparoscopic route during total laparoscopic hysterectomy.

Locations

Country Name City State
Turkey Department of Obstetrics and Gynecology, Istanbul University School of Medicine Istanbul

Sponsors (2)

Lead Sponsor Collaborator
Istanbul University University of Surrey

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Female Sexual Function Patients will be asked to fill out female sexual function index (FSFI) prior to surgery and at the 3-month follow-up. Three months No
Primary Vaginal length Vaginal measure will be taken prior to surgery and at 1-month follow-up. One months No
Secondary Vaginal cuff granulation/infection Vaginal cuff granulation and any evidence of vaginal cuff infection will be carefully examined and documented during the 4-week follow-up visit One month No
Secondary Vaginal cuff closure time Cuff closure time will be recorded for each patient during the surgery. One day No
See also
  Status Clinical Trial Phase
Completed NCT04082039 - Two-channel Intravenous Patient-controlled Analgesia (IV-PCA) After Total Laparoscopic Hysterectomy (TLH) N/A
Recruiting NCT05720884 - Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy N/A
Recruiting NCT06111404 - Urinary Bladder Dissection During Total Laparoscopic Hysterectomy in Cases With Previous Cesarean Section N/A
Completed NCT05003297 - Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) as an Inflammatory Markers to Predict Length of Hospital Stay After Total Laparoscopic Hysterectomy (TLH) for Benign Indications
Recruiting NCT01289314 - Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy N/A
Recruiting NCT05028543 - TLH With Prior Uterine Artery Clipping at Its Origin Versus Conventional TLH N/A
Completed NCT03310658 - Zip-Stitchâ„¢ for Vaginal Cuff Closure in Total Laparoscopic Hysterectomy N/A